5 employees
IM Therapeutics develops personalized immuno-therapeutic drugs.
2015
$10M
from 2 investors over 2 rounds
IM Therapeutics raised $10M on October 9, 2019
Investors: Morningside Venture Capital 晨兴资本 and JDRF T1D Fund